Adagio Medical Holdings, Inc.

For the period ended Dec 31, 2025. Filed Mar 27, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 27, 2026

ADGM$1.92Day change unavailableStored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(in thousands, except share and per share data)


· · Successor · · Successor
· · December 31, · · December 31,
· · 2025 · · 2024
Assets
Current assets:
Cash and cash equivalents	$17,105	$20,586
Accounts receivable, net	—	35
Inventory, net	1,672	2,566
Prepaid expenses	989	1,940
Other current assets	316	222
Total current assets	20,082	25,349
Property and equipment, net	1,535	1,961
Right-of-use assets, net	697	188
Intangible assets, net	6,969	6,969
Goodwill, net	13,967	13,967
Other assets	3	14
Total assets	$43,253	$48,448
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$1,082	$2,840
Accrued liabilities	6,996	3,676
Operating lease liabilities, current	155	143
Other accrued liabilities	—	1,104
Total current liabilities	8,233	7,763
Operating lease liabilities, long-term	563	46
Convertible notes payable, net	21,040	16,076
Warrant liabilities	132	152
Deferred tax liabilities, net	883	883
Other long-term liabilities	—	3,616
Total liabilities	30,851	28,536
Commitments and contingencies (Note 12)
Stockholders’ equity:
Common stock, $0.0001 par value; 210,000,000 shares authorized at December 31, 2025 and December 31, 2024; 22,210,459 and 15,198,232 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively	2	2
Additional paid-in capital	108,108	90,495
Accumulated other comprehensive (loss) income	(99)	1
Accumulated deficit	(95,609)	(70,586)
Total stockholders’ equity	12,402	19,912
Total liabilities and stockholders’ equity	$43,253	$48,448

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.